Literature DB >> 2664066

Regulation of T lymphocyte proliferation. Interleukin 2-mediated induction of c-myb gene expression is dependent on T lymphocyte activation state.

A M Churilla1, T J Braciale, V L Braciale.   

Abstract

We previously reported that with time, after antigenic stimulation of antigen-regulated murine T lymphocyte clones, total IL-2-R expression decayed 10-50-fold, commensurate with a decline in the ability of the cells to proliferate to IL-2. However, late after antigenic stimulation, when the cells were refractory to the IL-2-proliferative stimulus, high levels of high affinity IL-2-R remained. In this report we further explore the basis of unresponsiveness to IL-2 in the quiescent clones. We show that the proto-oncogene c-myc is induced in the late cell population by IL-2 to comparable levels observed early after antigen stimulation. IL-2-dependent c-myb induction, however, is seen only early after activation but not in the late-activated population. Analysis of the IL-2-dependent expression of c-myb mRNA with time after antigenic stimulation showed that steadystate c-myb expression declines dramatically with kinetics closely paralleling a decay in IL-2-dependent proliferative ability. In contrast, steadystate c-myc expression remains high throughout this period. Expression of c-myb is critical for proliferation of these cells since antisense oligodeoxy-nucleotide to c-myb can inhibit their IL-2-dependent proliferation. We present evidence for a pathway of c-myb induction via the TCR that is independent of the IL-2/IL-2-R interaction. In addition, the inhibition of IL-2-R-induced c-myb expression by 2-aminopurine and enhanced induction of c-myb via the TCR demonstrate that TCR activation and IL-2-R activation lead to induction of c-myb by different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2664066      PMCID: PMC2189389          DOI: 10.1084/jem.170.1.105

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Multilineage hematopoietic disorders induced by transplantation of bone marrow cells expressing the v-fms oncogene.

Authors:  J M Heard; M F Roussel; C W Rettenmier; C J Sherr
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

2.  Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.

Authors:  M A Shipp; E L Reinherz
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

3.  The c-myc gene encodes superimposed RNA polymerase II and III promoters.

Authors:  J Chung; D J Sussman; R Zeller; P Leder
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

4.  Kinetics of cellular oncogene expression in mouse lymphocytes. II. Regulation of c-fos and c-myc gene expression.

Authors:  J Schneider-Schaulies; A Schimpl; E Wecker
Journal:  Eur J Immunol       Date:  1987-05       Impact factor: 5.532

5.  Internalization of interleukin 2 (IL-2) by high affinity IL-2 receptors is required for the growth of IL-2-dependent T cell lines.

Authors:  A Kumar; J L Moreau; M Gibert; J Thèze
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

6.  The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes.

Authors:  S Yokota; D Yuan; T Katagiri; R A Eisenberg; P L Cohen; J P Ting
Journal:  J Immunol       Date:  1987-10-15       Impact factor: 5.422

7.  Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants.

Authors:  J L Cleveland; U R Rapp; W L Farrar
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

8.  A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.

Authors:  R Heikkila; G Schwab; E Wickstrom; S L Loke; D H Pluznik; R Watt; L M Neckers
Journal:  Nature       Date:  1987 Jul 30-Aug 5       Impact factor: 49.962

9.  Proto-oncogene expression in cloned T lymphocytes: mitogens and growth factors induce different patterns of expression.

Authors:  J C Reed; J D Alpers; P A Scherle; R G Hoover; P C Nowell; M B Prystowsky
Journal:  Oncogene       Date:  1987-05       Impact factor: 9.867

10.  Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deoxy-oligonucleotide in human T lymphocytes.

Authors:  A Harel-Bellan; D K Ferris; M Vinocour; J T Holt; W L Farrar
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

View more
  11 in total

Review 1.  Cytokine receptors: structure and signal transduction.

Authors:  B M Foxwell; K Barrett; M Feldmann
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

2.  The cellular proto-oncogene product Myb acts as transcriptional activator of the long terminal repeat of human T-lymphotropic virus type I.

Authors:  P Dasgupta; C D Reddy; P Saikumar; E P Reddy
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

3.  Identification of an inducible regulator of c-myb expression during T-cell activation.

Authors:  S C Phan; B Feeley; D Withers; L M Boxer
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

4.  c-Myb transcription is activated by protein kinase B (PKB) following interleukin 2 stimulation of Tcells and is required for PKB-mediated protection from apoptosis.

Authors:  A Lauder; A Castellanos; K Weston
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

5.  Inhibition of T-cell proliferation by a MYB antisense oligomer is accompanied by selective down-regulation of DNA polymerase alpha expression.

Authors:  D Venturelli; S Travali; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  Requirement of c-myb in T cell development and in mature T cell function.

Authors:  Yen K Lieu; Atul Kumar; Anthony G Pajerowski; Thomas J Rogers; E Premkumar Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-04       Impact factor: 11.205

7.  Nucleotide preferences in sequence-specific recognition of DNA by c-myb protein.

Authors:  K M Howe; R J Watson
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

8.  Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity.

Authors:  P Salomoni; D Perrotti; R Martinez; C Franceschi; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

9.  Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine.

Authors:  L A Turka; J Dayton; G Sinclair; C B Thompson; B S Mitchell
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

10.  Receptor antagonist and selective agonist derivatives of mouse interleukin-2.

Authors:  S M Zurawski; G Zurawski
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.